Introduction. Renal involvement in systemic lupus erythematosus (SLE) is associated with production of antibodies to double stranded DNA, deposition of immune complexes and organ damage. These processes have been linked with abnormalities in B-and T-cell memory compartments. The aim of the study was to analyze subsets of peripheral memory B-cells and T-cells in lupus nephritis (LN) patients. Material and methods. We used multicolor flow cytometry to analyze major memory subsets of peripheral blood B-cells (defined by CD27, IgD and CD21) and T-cells (CD45RA, CD45RO, CCR7) in 32 patients with active or inactive LN, and 23 control subjects. Results. Lupus nephritis patients were characterized by increased percentage of immature/early-transitional B-cells (CD27-IgD+CD21-), higher frequency of activated switched memory (SM, CD27+IgD-CD21-) and exhausted memory B-cells (CD27-IgD-), and decrease in non-switched memory (NSM, CD27+IgD+) B-cells. CD21 low subsets (immature and activated B-cells) were particularly expanded in patients with active disease. In both groups of LN patients we observed decline in the absolute count of NSM B-cells. It was paralleled by lymphopenia in naïve CD4+ T-cell compartment and increase in the frequency of effector memory T-cells, and these changes were more pronounced in active LN. Conclusions. B-cell memory compartment in LN is deficient in NSM cells and during active disease it is further skewed towards SM and exhausted memory phenotypes, most likely as a cause of chronic antigenic stimulation. Parallel changes in T-helper cell subsets suggest a similar mechanism of SLE-related lymphopenia for both B-cell and T-cell compartment.
Introduction
Systemic lupus erythematosus (SLE) is a complex autoimmune disorder with B-cell hyper-reactivity, immune complex deposition, and organ damage. Lupus nephritis (LN) develops in ~50% SLE patients, representing the main cause of morbidity and mortality [1, 2] . The significance of self-reacting B-cells in the pathogenesis of LN is supported by a strong causal link between autoantibodies against double stranded DNA (dsDNA) and renal involvement [3, 4] . Additionally, rise in the titer of anti-dsDNA antibodies occurs years before the clinical onset of proliferative LN [5, 6] . It has been suggested that autoimmune inflammation results from repeated stimulation of autoreactive memory T-and B-cells, and subsequent effector responses mediated in part by circulating autoantibodies.
During primary immune response to T-cell dependent (TD) antigens naïve B-cells receive signals from T-helper cells and proliferate rapidly forming germinal centers (GC) in lymphoid tissues. Many of responding B-cells undergo somatic hypermutation and class switching [7] . Memory B-cells generated during GC reaction can be recognized by surface expression of CD27, and are classified as switched memory cells (SM; CD27+IgD-), or non-switched (i.e. IgM+) memory cells (NSM; CD27+IgD+) [8] . During secondary antigen exposure SM B-cells proliferate rapidly and differentiate into antibody secreting cells, while NSM cells are able to reinitiate GC reaction and replenish SM fraction [9, 10] . Because B-cell response to nuclear auto-antigens requires T-cell help, formation of pathogenic autoantibodies in SLE (e.g. anti-dsDNA) follows the same rules [11] . As a consequence, in all SLE patients a pool of autoreactive memory B-and T-cells is steadily generated. It has been hypothesized that continuous presence to autoantigens favors differentiation of effector memory (EM) T-cells, which mount a pathogenic inflammatory response upon re-exposure to self-antigens [12] . Similarly to other memory cells, they are long-lived and difficult to eliminate, thus pose a considerable therapeutic challenge [13] .
Lymphocyte phenotyping in SLE patients revealed expansion of CD27+ memory B-cells with parallel decline in naïve compartment, but little is known if they are intrinsic or develop secondarily to disease-related inflammation [14] [15] [16] . Interestingly, memory B-cells in lupus patients often display 'double negative' (i.e. CD27-IgD-) phenotype and correlate with renal involvement [17, 18] . Additionally, several groups reported on marked decline in the frequency of CD27+IgD+ B-cells (NSM) mostly in patients with active disease [18] [19] [20] . B-cell lymphopenia is another typical feature of SLE, but less is known if it affects all B-cell subsets, and whether it is associated with similar abnormalities in T-cell compartment. Therefore in this study we aimed to analyze subsets of circulating B-cells in LN patients, in search for potential markers associated with disease activity. Additionally, we compared changes in B-cell and T-cell subsets depending on SLE-related lymphopenia.
Material and methods
Characteristics of the patients. Blood samples were taken from 34 systemic lupus erythematosus (SLE) patients with renal involvement, and 23 control subjects (apparently healthy, with negative laboratory tests for antinuclear and antiphospholipid autoantibodies). SLE was diagnosed based on updated criteria of the American College of Rheumatology [21] . LN was confirmed by renal biopsy and classified according to International Society of Nephrology/Renal Pathology Society (ISN/RPS) criteria [22] as class II (3%), III (15%), IV (56%) or V (8%). In 6 patients (18%) LN was diagnosed based on overt renal symptoms (proteinuria, active urinary sediment) during lupus flare. We enrolled 16 LN patients with disease exacerbation (active-LN, SLE Disease Activity Index [SLEDAI] > 6, urine protein > 1 g/day or > 2-fold increase with active urinary sediment) and 18 patients in remission (inactive-LN, SLEDAI £ 6, urine protein < 1 and normal urinary sediment) [23] . All but one active-LN patients had additional SLE symptoms: hematologic (88%, mostly lymphopenia), joint symptoms (50%), skin lesions (50%), and pleuritis (19%). LN patients were not treated with biological agents targeting B-cells (e.g. rituximab). Additionally, they were not treated with cyclophosphamide in the preceding 6 months. The clinical and laboratory characteristics of LN patients are summarized in Table 1 . The study was approved by the Ethics Committee of the Jagiellonian University and informed written consent was obtained from all participants.
Flow cytometry. Aliquots of EDTA anticoagulated blood were stained with a mixture of monoclonal antibodies (all from BD Biosciences, Franklin Lakes, NJ, USA) for detection of CD19+ B-cell (anti-CD45, CD3, CD19, CD21, CD27, IgD; gating strategy shown in Figures 1A, B) and T-cell memory subpopulations (anti-CD45, CD3, CD4, CD8, CD45RA, CD45RO, CCR7). Samples were fixed with FACS lysing solution (BD Biosciences), washed and analyzed in FACS Canto II flow cytometer (BD Biosciences). Based on differential expression of surface markers the following B-cell subsets were identified: immature/ /early-transitional (I/T, CD27-IgD+CD21 low ), late-transitional/naïve (CD27-IgD+CD21+), non-switched memory (NSM, CD27+IgD+), resting class-switched memory (SM, CD27+IgD-CD21+), activated SM (CD27+IgD-CD21 low ), and double-negative (CD27-IgD-) exhausted memory (ExM) as summarized in Figure 1C [8, 16, 23, 25] . Using T-cell panel we identified four subsets within CD4+ or CD8+ gate: naïve (CD45RA+CD45RO-CCR7+), central memory (T CM , CD45RA-CD45RO+CCR7+), effector memory (T EM , CD45RA-CD45RO+CCR7-), and effector memory CD45RA+ (T EMRA , CD45RA+CD45RO-CCR7-) [26, 27] .
Statistical methods. Statistical analysis was performed using GraphPad Prism 5.0 (GraphPad Software, Inc., San Diego, CA, USA). Data is presented as medians and 25-75 quartile ranges if not otherwise stated. Differences between two groups were determined by a Mann-Whitney U test. Differences between at least three groups were determined by ANOVA or Kruskal-Wallis test if justified. Spearman's rank sum test was used to analyze correlation coefficients. P value < 0.05 was considered significant.
Results

Decreased frequency of non-switched memory B-cells and signs of B-cell exhaustion in LN
The phenotypic characteristics of the analyzed B-cell subsets have been shown in Figure 1C . There was a large variability in the percentage of CD19+ B-cells in LN patients, with no difference in comparison with control group. B-cell counts were significantly lower in LN patients both with active and inactive disease Figure 1D ). LN patients showed high variability in the distribution of main B-cell subsets, which was more evident in patients with the active disease ( Figure 1E ). The percentage of early-transitional B-cells (CD27-IgD+CD21 low ) was increased in the active LN (median 6.5% of CD19+) as compared with inactive LN (3.0%, P < 0.05) and control (2.1%, P < 0.01) groups ( Figure 1F ). In all patients with active LN, and in majority (n = 15, 83%) of patients with inactive disease, we observed a marked decrease (median 2.4% and 2.3%, respectively) in the percentage of NSM B-cells ( Figure 1E , F) as compared with control subjects (13.4%). This was a characteristic feature of B-cell memory compartment, distinctive to SLE ( Figure 1G ). Additionally, we observed increased frequency of activated SM cells in active LN (median 12.6%) as compared with other groups (inactive LN -6.0%, P < 0.05, control -2.5%, P < 0,01).
Moreover, B-cell compartment in LN patients had signs of memory exhaustion, as evidenced ( Figure 1E , F) by increased percentage of double negative (CD27--IgD-) CD19+ B-cells (median 6.8% in active-and 9.9% in inactive-LN vs. 2.4% in control group, P < 0.01). Next, we compared absolute counts of B-cells in order to identify changes associated with SLE-induced lymphopenia. As shown in Figure 1H , there was a strong (> 10-fold) decrease in the number of NSM B-cells in LN patients (independently of the activity of the disease) as compared with control group, but we also found a significant, though less pronounced decrease in the count of naïve and resting SM B-cells.
Subsets of CD21 low B-cells correlate with LN activity
Overall, there was a strong association of B-cells with decreased expression of CD21 (comprised of early-transitional and activated/exhausted B-cells) with the activity of the disease (Figure 2A ). In particular, we showed a correlation ( Figure 2B , C) between the percentage of immature/early-transitional B-cells and various markers of SLE activity, e.g. SLEDAI According to International Society of Nephrology/Renal Pathology Society criteria [22] . Data are presented as medians [25-75 quartiles] . * , **P < 0.05 and *P < 0.01, respectively, in comparison with control group; #, ## P < 0.05 and P < 0.01, respectively, in comparison with Inactive LN. Abbreviations: ANA -anti-nuclear antibodies; C3c -complement component C3c; CRP -C-reactive protein; CTX -cyclophosphamide; GCS -glucocorticoids (recounted for methylprednisolone); LN -lupus nephritis; SLEDAI -SLE disease activity index; WBC -white blood cells 
Increased percentage of effector memory T-cells in LN
The decrease in absolute number of T-cells was comparable in active-and inactive-LN (median 514 and 700 cells/μL, respectively, vs. 1388 in control subjects, P < 0.01) and affected mostly CD4+ T-cells (237 and 409 cells/μL in LN groups vs. 923 in controls, P < 0.01) resulting in lower percentage of CD4+ T-cell in LN (median 37% of total lymphocytes in all LN patients vs. 47% in controls) and decreased CD4/CD8 ratio (1.01 and 1.67 in active-and inactive-LN vs. 2.37 in controls, P < 0.01). Additional staining for CD45RA, CD45RO and CCR7 ( Figure 3A ) allowed for identification of naïve and memory T-cell subsets ( Figure 3B ).
The main feature of T-cell compartment in LN was a significant decrease in the percentage of naïve T-helper cells (36.8% in LN vs. 48.0% in control group, P < 0.05) and increase in the percentage of T EM subset (29.7% vs. 14.5%, respectively, P < 0.01), with no difference between active and inactive disease ( Figure 3C ). The frequency of CD8+ T-cell subsets did not change considerably in LN ( Figure 3C ). Further analysis showed significant decrease in the absolute count of naïve and T CM cells (primarily CD4+) in LN as compared with control subjects, which was more prominent in the active disease ( Figure 3D ). Comparison of B-cell and T-cell memory fractions revealed a weak correlation of the percentage of CD4+ T EM with both NSM (r = -0.42) and ExM B-cells (r = 0.48). Not surprisingly, there was a considerable correlation between the magnitude in the decrease of absolute counts of CD4+ T and B fractions, which was most prominent in case of naïve CD4+ and NSM B-cells ( Figure 3F ). 
Memory B-and T-cell subsets in lupus nephritis
Discussion
Earlier studies showed specific changes in B-cell compartment in SLE, though data on the association between various memory B-cells and disease activity are inconsistent [18, 28, 29] . To address this point we quantified different subsets of B-cells in patients with inactive LN and during disease exacerbations, and also checked if they are paralleled by similar changes within T-cell memory compartment. We defined main subsets of B-cells based on multicolor flow cytometry panel, including staining for CD27 (memory marker), surface-IgD and CD21 (complement receptor CR2, a component of BCR co-receptor complex), which allowed to distinguish switched and non-switched memory B-cells and additionally CD21 low immature and activated B-cells.
Decreased frequency of NSM B-cells was the most prominent feature of LN in the current study. This alteration was observed in all LN patients with disease exacerbation and in a majority (83%) of patients in remission. Our data is in line with previous reports showing deficiency in CD27+IgD+ cells in SLE [18, 19] , though in contrast to earlier study [18] , we did not see any association of B-cell NSM percentage with disease activity status. The subset of NSM B-cells has been implicated in immune responses against T-cell independent antigens, however recent studies confirmed their role as a long-lasting memory to T-cell dependent antigens involved in reconstitution of switched memory pool upon antigen restimulation [10] . Changes in NSM fraction were accompanied by increased percentage of immature/ /early-transitional B-cells and activated SM cells, both [8, 16, 23] . Nevertheless, systemic accumulation of B-cells with CD27+CD21 low phenotype, e.g. during chronic viral infections, is also considered as a sign of aberrant B-cell activation and dysfunction within the memory compartment [21, 30] . In this study we observed very similar B-cell changes in LN patients. The fraction of activated SM B-cells (CD27+CD21 low ) was ~3-fold higher in patients with active LN as compared with control group. In line with previous reports [17, 18, 29] , we also observed increased frequency of double negative (i.e. CD27-IgD-) B-cells in patients with LN. This fraction represents class--switched memory cells that lost CD27 expression, which are also markedly expanded during chronic infections, and resemble tissue-like exhausted memory B-cells [23, 32] . These results suggest altogether that reduction in NSM B-cells is most likely a consequence of facilitated class switch of IgM+ memory cells and further differentiation towards SM-activated and exhausted memory phenotypes. This was further confirmed by analysis of absolute counts of B-cells. As it turned out, SLE related lymphopenia affected mostly naïve and NSM B-cells, but again, with no evident association with disease activity status. Moreover, despite clear increase in the percentage of immature/ /early-transitional cells, there was no change in their absolute count. This observation confirms that bone marrow production of B-cells is not disturbed in SLE, as has been suggested previously [33] . Instead, our results support the concept on preferential depletion of IgM+ memory pool in LN due to their constant activation (repeated exposure to self-antigens) and continuous replenishing of SM-pool. However other explanations, e.g. abnormal selection processes or diminished susceptibility of particular memory B-cells to immunosuppressive drugs, are still possible. But autoreactive B-cells are only a tiny fraction of all memory cells, so why the whole compartment is changed? Some hints came from recent study, showing that various neutrophil-derived proinflammatory mediators facilitate differentiation of IgD+ CD27+ memory B-cells and IgG class switch [10] . Neutrophils participate in the pathogenesis of LN, and both neutrophil derived cytokines (e.g. CCL2) and markers of neutrophil activation (extracellular traps) correlate with the activity of glomerulonephritis and dsDNA titers [34, 35] . This implies that B-cell memory compartment in LN may also be shaped by innate immunity mediators released at the site of autoimmune inflammation. Because class switching and B-cell activation are under strict control of T-helper cells we further explored if similar changes of immune memory developed also in T-cell compartment.
A characteristic feature of systemic autoimmunity is constant exposure to tissue antigens, which favors differentiation of long-lasting T EM cells with well-developed effector functions [12] . In SLE this phenomenon may be associated with impaired immunosuppression, due to persistently lower numbers of regulatory T-cells or their impaired function [36, 37] . Similarly to previous report [38] , we observed lower frequency of naïve CD4+ T-cells and increased percentage of T EM fraction in both active-and inactive-LN. Additionally, we showed that SLE-related lymphopenia affected mostly naïve CD4+ lymphocytes. The reasons for decreased CD4+ lymphocyte count in SLE are, however, poorly understood. It may result from higher susceptibility of T-cells to apoptosis due to diminished expression of complement regulatory proteins or defective Fas/Fas-ligand system [39] . The depletion of lymphocytes may also be linked with anti-lymphocyte antibodies, which are detected in ~50% of SLE patients presenting with lymphopenia [40] . Interestingly, we observed comparable decrease (~10-fold) in absolute counts of antigen inexperienced T-cells and NSM B-cells. We also showed a correlation between the percentage of naïve fractions of B-cells and CD4+ T-cells, as well as between their mature subsets. This observation suggests that chronic antigenic stimulation and facilitated shift towards T EM may also contribute to lymphopenia in T-cell compartment. It is also tempting to speculate that decline in one compartment, e.g. in CD4+ T-cells, may trigger similar changes in the other. It has been shown that transient depletion of B cells can potently influence reactivation and maintenance of pathogen specific CD4+ T cells [40] . However, there are only scarce data on possible interaction between CD4+ lymphopenia and the concomitant quantitative changes in B cell subsets [23, 42] .
The presented data highlight similarities in changes of B-cell and CD4+ T-cell subsets in LN patients, including deficiency in naïve (or non-switched) cells in all SLE patients and relative increase in effector memory (or exhausted) subsets during overt disease. LN-related changes in B-cell memory compartment, particularly the decline in NSM B-cells, may result from chronic antigenic stimulation and facilitated differentiation towards mature memory phenotypes, though it does not exclude possible intrinsic abnormalities related to abnormal selection processes or varying sensitivity to immunosuppressants. www.fhc.viamedica.pl the increase in CD21 low B-cells could be used as additional laboratory marker of active disease. Whether B-cell memory subsets are skewed to the same extent in other SLE manifestations, or their diagnostic potential in SLE remains to be further studied.
